FedEx says it meets COVID-19 vaccine delivery requirements

        FedEx said it has sufficient air freight capacity to meet the delivery requirements of the new crown vaccine. Perna, chief operating officer of "Action Curvature Speed", said that Pfizer's new crown pneumonia vaccine will be distributed through FedEx and UPS logistics.

　　 At the same time, FedEx will announce its financial results for the second quarter of fiscal year 2021 on December 17th after the US stock market, Eastern Time. The company's financial report is expected to exceed market expectations. UBS raised FedEx’s target price from US$320 to US$380.

　　 The bank said that it expects FedEx’s earnings in the second quarter to rise, raising its earnings per share forecast from US$3.82 to US$4.2.

　　Air freight rates in Asia have been rising continuously, which has provided support for the company’s performance. At the same time, it is believed that the continued growth momentum of e-commerce will provide it with strong revenue drivers.

　　 It is reported that FedEx has previously stated that it intends to acquire e-commerce platform ShopRunner, but did not disclose the specific price. This move means that the courier giant's growing competition with Amazon has added a new dimension.